nodes	percent_of_prediction	percent_of_DWPC	metapath
Ergonovine—Bromocriptine—type 2 diabetes mellitus	0.404	1	CrCtD
Ergonovine—HTR2C—type 2 diabetes mellitus	0.0964	0.667	CbGaD
Ergonovine—Methylergometrine—Bromocriptine—type 2 diabetes mellitus	0.0823	0.347	CrCrCtD
Ergonovine—Methysergide—Bromocriptine—type 2 diabetes mellitus	0.0823	0.347	CrCrCtD
Ergonovine—Ergotamine—Bromocriptine—type 2 diabetes mellitus	0.0727	0.307	CrCrCtD
Ergonovine—CYP3A4—type 2 diabetes mellitus	0.0482	0.333	CbGaD
Ergonovine—HTR2C—Bromocriptine—type 2 diabetes mellitus	0.0199	0.137	CbGbCtD
Ergonovine—ADRA1A—Bromocriptine—type 2 diabetes mellitus	0.0172	0.119	CbGbCtD
Ergonovine—ABCB1—Linagliptin—type 2 diabetes mellitus	0.0143	0.0987	CbGbCtD
Ergonovine—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.0128	0.0879	CbGbCtD
Ergonovine—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.00923	0.0636	CbGbCtD
Ergonovine—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.00858	0.0591	CbGbCtD
Ergonovine—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.00765	0.0527	CbGbCtD
Ergonovine—CYP3A4—Glipizide—type 2 diabetes mellitus	0.00699	0.0482	CbGbCtD
Ergonovine—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.00634	0.0437	CbGbCtD
Ergonovine—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00611	0.0421	CbGbCtD
Ergonovine—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00553	0.0381	CbGbCtD
Ergonovine—ABCB1—Glyburide—type 2 diabetes mellitus	0.00472	0.0325	CbGbCtD
Ergonovine—ABCB1—Losartan—type 2 diabetes mellitus	0.00432	0.0298	CbGbCtD
Ergonovine—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00419	0.0289	CbGbCtD
Ergonovine—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00402	0.0277	CbGbCtD
Ergonovine—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00402	0.0277	CbGbCtD
Ergonovine—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.0038	0.0262	CbGbCtD
Ergonovine—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00283	0.0195	CbGbCtD
Ergonovine—CYP3A4—Losartan—type 2 diabetes mellitus	0.00259	0.0178	CbGbCtD
Ergonovine—Acute coronary syndrome—Rosiglitazone—type 2 diabetes mellitus	0.000251	0.00536	CcSEcCtD
Ergonovine—Myocardial infarction—Rosiglitazone—type 2 diabetes mellitus	0.000249	0.00533	CcSEcCtD
Ergonovine—Vertigo—Tolazamide—type 2 diabetes mellitus	0.000236	0.00504	CcSEcCtD
Ergonovine—Drug interaction—Irbesartan—type 2 diabetes mellitus	0.000234	0.00501	CcSEcCtD
Ergonovine—Thrombophlebitis—Gliclazide—type 2 diabetes mellitus	0.000231	0.00493	CcSEcCtD
Ergonovine—Cramps of lower extremities—Orlistat—type 2 diabetes mellitus	0.000229	0.00491	CcSEcCtD
Ergonovine—Palpitations—Nateglinide—type 2 diabetes mellitus	0.000215	0.00459	CcSEcCtD
Ergonovine—Gastrointestinal pain—Miglitol—type 2 diabetes mellitus	0.000214	0.00458	CcSEcCtD
Ergonovine—Sweating—Glipizide—type 2 diabetes mellitus	0.000213	0.00457	CcSEcCtD
Ergonovine—Acute coronary syndrome—Pioglitazone—type 2 diabetes mellitus	0.00021	0.0045	CcSEcCtD
Ergonovine—Myocardial infarction—Pioglitazone—type 2 diabetes mellitus	0.000209	0.00447	CcSEcCtD
Ergonovine—Abdominal pain—Miglitol—type 2 diabetes mellitus	0.000207	0.00442	CcSEcCtD
Ergonovine—Sweating—Pioglitazone—type 2 diabetes mellitus	0.000204	0.00437	CcSEcCtD
Ergonovine—Haematuria—Pioglitazone—type 2 diabetes mellitus	0.000203	0.00435	CcSEcCtD
Ergonovine—Sweating—Glimepiride—type 2 diabetes mellitus	0.000199	0.00426	CcSEcCtD
Ergonovine—Pulmonary oedema—Irbesartan—type 2 diabetes mellitus	0.000193	0.00414	CcSEcCtD
Ergonovine—Hyperhidrosis—Nateglinide—type 2 diabetes mellitus	0.000192	0.0041	CcSEcCtD
Ergonovine—Bradycardia—Glimepiride—type 2 diabetes mellitus	0.00019	0.00406	CcSEcCtD
Ergonovine—Drug interaction—Ramipril—type 2 diabetes mellitus	0.000189	0.00404	CcSEcCtD
Ergonovine—Palpitations—Repaglinide—type 2 diabetes mellitus	0.000186	0.00398	CcSEcCtD
Ergonovine—Acute coronary syndrome—Bromocriptine—type 2 diabetes mellitus	0.000185	0.00395	CcSEcCtD
Ergonovine—Myocardial infarction—Bromocriptine—type 2 diabetes mellitus	0.000184	0.00393	CcSEcCtD
Ergonovine—Nasal congestion—Metformin—type 2 diabetes mellitus	0.000183	0.00392	CcSEcCtD
Ergonovine—Pulmonary oedema—Losartan—type 2 diabetes mellitus	0.000182	0.00389	CcSEcCtD
Ergonovine—Hypertension—Repaglinide—type 2 diabetes mellitus	0.000182	0.00388	CcSEcCtD
Ergonovine—Chest pain—Repaglinide—type 2 diabetes mellitus	0.000179	0.00383	CcSEcCtD
Ergonovine—Diarrhoea—Miglitol—type 2 diabetes mellitus	0.000179	0.00383	CcSEcCtD
Ergonovine—Hypertension—Rosiglitazone—type 2 diabetes mellitus	0.000172	0.00367	CcSEcCtD
Ergonovine—Bradycardia—Bromocriptine—type 2 diabetes mellitus	0.000171	0.00366	CcSEcCtD
Ergonovine—Gastrointestinal pain—Acarbose—type 2 diabetes mellitus	0.000168	0.0036	CcSEcCtD
Ergonovine—Hallucination—Bromocriptine—type 2 diabetes mellitus	0.000167	0.00358	CcSEcCtD
Ergonovine—Muscle spasms—Glipizide—type 2 diabetes mellitus	0.000167	0.00358	CcSEcCtD
Ergonovine—Nasal congestion—Losartan—type 2 diabetes mellitus	0.000163	0.00348	CcSEcCtD
Ergonovine—Abdominal pain—Acarbose—type 2 diabetes mellitus	0.000163	0.00348	CcSEcCtD
Ergonovine—Gastrointestinal pain—Nateglinide—type 2 diabetes mellitus	0.000162	0.00347	CcSEcCtD
Ergonovine—Muscle spasms—Pioglitazone—type 2 diabetes mellitus	0.00016	0.00343	CcSEcCtD
Ergonovine—Tinnitus—Bromocriptine—type 2 diabetes mellitus	0.000157	0.00336	CcSEcCtD
Ergonovine—Abdominal pain—Nateglinide—type 2 diabetes mellitus	0.000157	0.00335	CcSEcCtD
Ergonovine—Vertigo—Glipizide—type 2 diabetes mellitus	0.000156	0.00334	CcSEcCtD
Ergonovine—Muscle spasms—Sitagliptin—type 2 diabetes mellitus	0.000156	0.00333	CcSEcCtD
Ergonovine—Nausea—Miglitol—type 2 diabetes mellitus	0.000155	0.00332	CcSEcCtD
Ergonovine—Acute coronary syndrome—Gliclazide—type 2 diabetes mellitus	0.000152	0.00324	CcSEcCtD
Ergonovine—Myocardial infarction—Gliclazide—type 2 diabetes mellitus	0.000151	0.00323	CcSEcCtD
Ergonovine—Hypertension—Glipizide—type 2 diabetes mellitus	0.00015	0.00321	CcSEcCtD
Ergonovine—Vertigo—Pioglitazone—type 2 diabetes mellitus	0.00015	0.0032	CcSEcCtD
Ergonovine—Methylergometrine—HTR2C—type 2 diabetes mellitus	0.000148	0.0971	CrCbGaD
Ergonovine—Sweating—Gliclazide—type 2 diabetes mellitus	0.000147	0.00316	CcSEcCtD
Ergonovine—Headache—Tolbutamide—type 2 diabetes mellitus	0.000147	0.00315	CcSEcCtD
Ergonovine—Diarrhoea—Chlorpropamide—type 2 diabetes mellitus	0.000146	0.00313	CcSEcCtD
Ergonovine—Vertigo—Sitagliptin—type 2 diabetes mellitus	0.000145	0.00311	CcSEcCtD
Ergonovine—Diarrhoea—Linagliptin—type 2 diabetes mellitus	0.000145	0.0031	CcSEcCtD
Ergonovine—Hypertension—Pioglitazone—type 2 diabetes mellitus	0.000144	0.00308	CcSEcCtD
Ergonovine—Palpitations—Glimepiride—type 2 diabetes mellitus	0.000143	0.00307	CcSEcCtD
Ergonovine—Chest pain—Pioglitazone—type 2 diabetes mellitus	0.000142	0.00304	CcSEcCtD
Ergonovine—Dizziness—Chlorpropamide—type 2 diabetes mellitus	0.000142	0.00303	CcSEcCtD
Ergonovine—Dizziness—Tolazamide—type 2 diabetes mellitus	0.000142	0.00303	CcSEcCtD
Ergonovine—Muscle spasms—Bromocriptine—type 2 diabetes mellitus	0.000141	0.00301	CcSEcCtD
Ergonovine—Diarrhoea—Acarbose—type 2 diabetes mellitus	0.000141	0.00301	CcSEcCtD
Ergonovine—Bradycardia—Gliclazide—type 2 diabetes mellitus	0.000141	0.00301	CcSEcCtD
Ergonovine—Gastrointestinal pain—Repaglinide—type 2 diabetes mellitus	0.00014	0.003	CcSEcCtD
Ergonovine—Hypertension—Glimepiride—type 2 diabetes mellitus	0.00014	0.003	CcSEcCtD
Ergonovine—Nausea—Tolbutamide—type 2 diabetes mellitus	0.00014	0.00299	CcSEcCtD
Ergonovine—Hypertension—Sitagliptin—type 2 diabetes mellitus	0.00014	0.00299	CcSEcCtD
Ergonovine—Shock—Glipizide—type 2 diabetes mellitus	0.00014	0.00299	CcSEcCtD
Ergonovine—Nasal congestion—Ramipril—type 2 diabetes mellitus	0.00014	0.00299	CcSEcCtD
Ergonovine—Hyperhidrosis—Glipizide—type 2 diabetes mellitus	0.000137	0.00294	CcSEcCtD
Ergonovine—Vomiting—Chlorpropamide—type 2 diabetes mellitus	0.000136	0.00291	CcSEcCtD
Ergonovine—Abdominal pain—Repaglinide—type 2 diabetes mellitus	0.000136	0.0029	CcSEcCtD
Ergonovine—Diarrhoea—Nateglinide—type 2 diabetes mellitus	0.000136	0.0029	CcSEcCtD
Ergonovine—Headache—Tolazamide—type 2 diabetes mellitus	0.000134	0.00287	CcSEcCtD
Ergonovine—Headache—Chlorpropamide—type 2 diabetes mellitus	0.000134	0.00287	CcSEcCtD
Ergonovine—Headache—Linagliptin—type 2 diabetes mellitus	0.000133	0.00284	CcSEcCtD
Ergonovine—Vertigo—Bromocriptine—type 2 diabetes mellitus	0.000132	0.00282	CcSEcCtD
Ergonovine—Hyperhidrosis—Pioglitazone—type 2 diabetes mellitus	0.000132	0.00281	CcSEcCtD
Ergonovine—Dizziness—Nateglinide—type 2 diabetes mellitus	0.000131	0.00281	CcSEcCtD
Ergonovine—Vomiting—Acarbose—type 2 diabetes mellitus	0.000131	0.0028	CcSEcCtD
Ergonovine—Shock—Glimepiride—type 2 diabetes mellitus	0.00013	0.00279	CcSEcCtD
Ergonovine—Tinnitus—Gliclazide—type 2 diabetes mellitus	0.000129	0.00276	CcSEcCtD
Ergonovine—Hyperhidrosis—Glimepiride—type 2 diabetes mellitus	0.000128	0.00274	CcSEcCtD
Ergonovine—Nausea—Tolazamide—type 2 diabetes mellitus	0.000127	0.00272	CcSEcCtD
Ergonovine—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.000127	0.00272	CcSEcCtD
Ergonovine—Dyspnoea—Glipizide—type 2 diabetes mellitus	0.000127	0.00271	CcSEcCtD
Ergonovine—Hypertension—Bromocriptine—type 2 diabetes mellitus	0.000126	0.00271	CcSEcCtD
Ergonovine—Vomiting—Nateglinide—type 2 diabetes mellitus	0.000126	0.0027	CcSEcCtD
Ergonovine—Pergolide—ADRA2A—type 2 diabetes mellitus	0.000124	0.0815	CrCbGaD
Ergonovine—Hypotension—Glimepiride—type 2 diabetes mellitus	0.000124	0.00265	CcSEcCtD
Ergonovine—Methysergide—HTR2C—type 2 diabetes mellitus	0.000124	0.081	CrCbGaD
Ergonovine—Nausea—Acarbose—type 2 diabetes mellitus	0.000122	0.00261	CcSEcCtD
Ergonovine—Dyspnoea—Pioglitazone—type 2 diabetes mellitus	0.000121	0.00259	CcSEcCtD
Ergonovine—Acute coronary syndrome—Irbesartan—type 2 diabetes mellitus	0.00012	0.00256	CcSEcCtD
Ergonovine—Myocardial infarction—Irbesartan—type 2 diabetes mellitus	0.000119	0.00255	CcSEcCtD
Ergonovine—Dyspnoea—Glimepiride—type 2 diabetes mellitus	0.000118	0.00253	CcSEcCtD
Ergonovine—Nausea—Nateglinide—type 2 diabetes mellitus	0.000118	0.00252	CcSEcCtD
Ergonovine—Bradycardia—Metformin—type 2 diabetes mellitus	0.000118	0.00252	CcSEcCtD
Ergonovine—Shock—Bromocriptine—type 2 diabetes mellitus	0.000118	0.00252	CcSEcCtD
Ergonovine—Diarrhoea—Repaglinide—type 2 diabetes mellitus	0.000117	0.00251	CcSEcCtD
Ergonovine—Gastrointestinal pain—Glipizide—type 2 diabetes mellitus	0.000116	0.00248	CcSEcCtD
Ergonovine—Pergolide—HTR2C—type 2 diabetes mellitus	0.000114	0.075	CrCbGaD
Ergonovine—Abdominal pain—Glipizide—type 2 diabetes mellitus	0.000112	0.0024	CcSEcCtD
Ergonovine—Hypotension—Bromocriptine—type 2 diabetes mellitus	0.000112	0.00239	CcSEcCtD
Ergonovine—Bradycardia—Irbesartan—type 2 diabetes mellitus	0.000111	0.00238	CcSEcCtD
Ergonovine—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.000111	0.00237	CcSEcCtD
Ergonovine—Sweating—Losartan—type 2 diabetes mellitus	0.00011	0.00234	CcSEcCtD
Ergonovine—Vomiting—Repaglinide—type 2 diabetes mellitus	0.000109	0.00233	CcSEcCtD
Ergonovine—Gastrointestinal pain—Glimepiride—type 2 diabetes mellitus	0.000108	0.00232	CcSEcCtD
Ergonovine—Gastrointestinal pain—Sitagliptin—type 2 diabetes mellitus	0.000108	0.00231	CcSEcCtD
Ergonovine—Lisuride—ADRA2A—type 2 diabetes mellitus	0.000108	0.0707	CrCbGaD
Ergonovine—Headache—Repaglinide—type 2 diabetes mellitus	0.000108	0.0023	CcSEcCtD
Ergonovine—Shock—Glyburide—type 2 diabetes mellitus	0.000108	0.0023	CcSEcCtD
Ergonovine—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000107	0.00229	CcSEcCtD
Ergonovine—Dyspnoea—Bromocriptine—type 2 diabetes mellitus	0.000107	0.00228	CcSEcCtD
Ergonovine—Palpitations—Gliclazide—type 2 diabetes mellitus	0.000106	0.00227	CcSEcCtD
Ergonovine—Muscle spasms—Valsartan—type 2 diabetes mellitus	0.000106	0.00227	CcSEcCtD
Ergonovine—Hyperhidrosis—Glyburide—type 2 diabetes mellitus	0.000106	0.00226	CcSEcCtD
Ergonovine—Muscle spasms—Orlistat—type 2 diabetes mellitus	0.000105	0.00225	CcSEcCtD
Ergonovine—Abdominal pain—Glimepiride—type 2 diabetes mellitus	0.000105	0.00224	CcSEcCtD
Ergonovine—Abdominal pain—Sitagliptin—type 2 diabetes mellitus	0.000104	0.00223	CcSEcCtD
Ergonovine—Hypertension—Gliclazide—type 2 diabetes mellitus	0.000104	0.00222	CcSEcCtD
Ergonovine—Ergotamine—ADRA2A—type 2 diabetes mellitus	0.000104	0.068	CrCbGaD
Ergonovine—Chest pain—Gliclazide—type 2 diabetes mellitus	0.000102	0.00219	CcSEcCtD
Ergonovine—Hypotension—Glyburide—type 2 diabetes mellitus	0.000102	0.00218	CcSEcCtD
Ergonovine—Nausea—Repaglinide—type 2 diabetes mellitus	0.000102	0.00218	CcSEcCtD
Ergonovine—Tinnitus—Irbesartan—type 2 diabetes mellitus	0.000102	0.00218	CcSEcCtD
Ergonovine—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000102	0.00217	CcSEcCtD
Ergonovine—Bromocriptine—ADRA2A—type 2 diabetes mellitus	9.99e-05	0.0655	CrCbGaD
Ergonovine—Lisuride—HTR2C—type 2 diabetes mellitus	9.93e-05	0.0651	CrCbGaD
Ergonovine—Vertigo—Valsartan—type 2 diabetes mellitus	9.92e-05	0.00212	CcSEcCtD
Ergonovine—Vertigo—Orlistat—type 2 diabetes mellitus	9.81e-05	0.0021	CcSEcCtD
Ergonovine—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	9.78e-05	0.00209	CcSEcCtD
Ergonovine—Palpitations—Valsartan—type 2 diabetes mellitus	9.76e-05	0.00209	CcSEcCtD
Ergonovine—Dyspnoea—Glyburide—type 2 diabetes mellitus	9.74e-05	0.00208	CcSEcCtD
Ergonovine—Diarrhoea—Glipizide—type 2 diabetes mellitus	9.72e-05	0.00208	CcSEcCtD
Ergonovine—Muscle spasms—Metformin—type 2 diabetes mellitus	9.67e-05	0.00207	CcSEcCtD
Ergonovine—Acute coronary syndrome—Ramipril—type 2 diabetes mellitus	9.66e-05	0.00207	CcSEcCtD
Ergonovine—Palpitations—Orlistat—type 2 diabetes mellitus	9.65e-05	0.00206	CcSEcCtD
Ergonovine—Nausea—Rosiglitazone—type 2 diabetes mellitus	9.63e-05	0.00206	CcSEcCtD
Ergonovine—Myocardial infarction—Ramipril—type 2 diabetes mellitus	9.61e-05	0.00206	CcSEcCtD
Ergonovine—Tinnitus—Losartan—type 2 diabetes mellitus	9.57e-05	0.00205	CcSEcCtD
Ergonovine—Ergotamine—HTR2C—type 2 diabetes mellitus	9.54e-05	0.0626	CrCbGaD
Ergonovine—Hyperhidrosis—Gliclazide—type 2 diabetes mellitus	9.49e-05	0.00203	CcSEcCtD
Ergonovine—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	9.45e-05	0.00202	CcSEcCtD
Ergonovine—Chest pain—Valsartan—type 2 diabetes mellitus	9.4e-05	0.00201	CcSEcCtD
Ergonovine—Sweating—Ramipril—type 2 diabetes mellitus	9.4e-05	0.00201	CcSEcCtD
Ergonovine—Dizziness—Glipizide—type 2 diabetes mellitus	9.39e-05	0.00201	CcSEcCtD
Ergonovine—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	9.31e-05	0.00199	CcSEcCtD
Ergonovine—Chest pain—Orlistat—type 2 diabetes mellitus	9.29e-05	0.00199	CcSEcCtD
Ergonovine—Bromocriptine—HTR2C—type 2 diabetes mellitus	9.2e-05	0.0603	CrCbGaD
Ergonovine—Hypotension—Gliclazide—type 2 diabetes mellitus	9.17e-05	0.00196	CcSEcCtD
Ergonovine—Muscle spasms—Irbesartan—type 2 diabetes mellitus	9.13e-05	0.00195	CcSEcCtD
Ergonovine—Diarrhoea—Glimepiride—type 2 diabetes mellitus	9.07e-05	0.00194	CcSEcCtD
Ergonovine—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	9.04e-05	0.00193	CcSEcCtD
Ergonovine—Vomiting—Glipizide—type 2 diabetes mellitus	9.03e-05	0.00193	CcSEcCtD
Ergonovine—Dizziness—Pioglitazone—type 2 diabetes mellitus	9e-05	0.00192	CcSEcCtD
Ergonovine—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	8.94e-05	0.00191	CcSEcCtD
Ergonovine—Headache—Glipizide—type 2 diabetes mellitus	8.9e-05	0.0019	CcSEcCtD
Ergonovine—Palpitations—Metformin—type 2 diabetes mellitus	8.89e-05	0.0019	CcSEcCtD
Ergonovine—Shock—Valsartan—type 2 diabetes mellitus	8.87e-05	0.0019	CcSEcCtD
Ergonovine—Dizziness—Glimepiride—type 2 diabetes mellitus	8.76e-05	0.00187	CcSEcCtD
Ergonovine—Dyspnoea—Gliclazide—type 2 diabetes mellitus	8.75e-05	0.00187	CcSEcCtD
Ergonovine—Dizziness—Sitagliptin—type 2 diabetes mellitus	8.73e-05	0.00187	CcSEcCtD
Ergonovine—Hypertension—Metformin—type 2 diabetes mellitus	8.68e-05	0.00186	CcSEcCtD
Ergonovine—Abdominal pain—Glyburide—type 2 diabetes mellitus	8.64e-05	0.00185	CcSEcCtD
Ergonovine—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	8.61e-05	0.00184	CcSEcCtD
Ergonovine—Muscle spasms—Losartan—type 2 diabetes mellitus	8.59e-05	0.00184	CcSEcCtD
Ergonovine—Chest pain—Metformin—type 2 diabetes mellitus	8.56e-05	0.00183	CcSEcCtD
Ergonovine—Vertigo—Irbesartan—type 2 diabetes mellitus	8.53e-05	0.00182	CcSEcCtD
Ergonovine—Headache—Pioglitazone—type 2 diabetes mellitus	8.52e-05	0.00182	CcSEcCtD
Ergonovine—Nausea—Glipizide—type 2 diabetes mellitus	8.43e-05	0.0018	CcSEcCtD
Ergonovine—Vomiting—Glimepiride—type 2 diabetes mellitus	8.43e-05	0.0018	CcSEcCtD
Ergonovine—Hypotension—Valsartan—type 2 diabetes mellitus	8.42e-05	0.0018	CcSEcCtD
Ergonovine—Vomiting—Sitagliptin—type 2 diabetes mellitus	8.4e-05	0.0018	CcSEcCtD
Ergonovine—Headache—Glimepiride—type 2 diabetes mellitus	8.3e-05	0.00178	CcSEcCtD
Ergonovine—Headache—Sitagliptin—type 2 diabetes mellitus	8.27e-05	0.00177	CcSEcCtD
Ergonovine—Tinnitus—Ramipril—type 2 diabetes mellitus	8.2e-05	0.00176	CcSEcCtD
Ergonovine—Hypertension—Irbesartan—type 2 diabetes mellitus	8.2e-05	0.00175	CcSEcCtD
Ergonovine—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	8.18e-05	0.00175	CcSEcCtD
Ergonovine—Chest pain—Irbesartan—type 2 diabetes mellitus	8.08e-05	0.00173	CcSEcCtD
Ergonovine—Shock—Metformin—type 2 diabetes mellitus	8.08e-05	0.00173	CcSEcCtD
Ergonovine—Dyspnoea—Valsartan—type 2 diabetes mellitus	8.04e-05	0.00172	CcSEcCtD
Ergonovine—Vertigo—Losartan—type 2 diabetes mellitus	8.03e-05	0.00172	CcSEcCtD
Ergonovine—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	8.02e-05	0.00172	CcSEcCtD
Ergonovine—Hyperhidrosis—Metformin—type 2 diabetes mellitus	7.94e-05	0.0017	CcSEcCtD
Ergonovine—Dizziness—Bromocriptine—type 2 diabetes mellitus	7.9e-05	0.00169	CcSEcCtD
Ergonovine—Palpitations—Losartan—type 2 diabetes mellitus	7.9e-05	0.00169	CcSEcCtD
Ergonovine—Nausea—Glimepiride—type 2 diabetes mellitus	7.87e-05	0.00168	CcSEcCtD
Ergonovine—Nausea—Sitagliptin—type 2 diabetes mellitus	7.85e-05	0.00168	CcSEcCtD
Ergonovine—Abdominal pain—Gliclazide—type 2 diabetes mellitus	7.76e-05	0.00166	CcSEcCtD
Ergonovine—Hypotension—Metformin—type 2 diabetes mellitus	7.67e-05	0.00164	CcSEcCtD
Ergonovine—Shock—Irbesartan—type 2 diabetes mellitus	7.62e-05	0.00163	CcSEcCtD
Ergonovine—Chest pain—Losartan—type 2 diabetes mellitus	7.61e-05	0.00163	CcSEcCtD
Ergonovine—Vomiting—Bromocriptine—type 2 diabetes mellitus	7.6e-05	0.00163	CcSEcCtD
Ergonovine—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	7.49e-05	0.0016	CcSEcCtD
Ergonovine—Headache—Bromocriptine—type 2 diabetes mellitus	7.49e-05	0.0016	CcSEcCtD
Ergonovine—Diarrhoea—Glyburide—type 2 diabetes mellitus	7.48e-05	0.0016	CcSEcCtD
Ergonovine—Methylergometrine—CYP3A4—type 2 diabetes mellitus	7.39e-05	0.0485	CrCbGaD
Ergonovine—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	7.37e-05	0.00158	CcSEcCtD
Ergonovine—Muscle spasms—Ramipril—type 2 diabetes mellitus	7.37e-05	0.00158	CcSEcCtD
Ergonovine—Dyspnoea—Metformin—type 2 diabetes mellitus	7.32e-05	0.00157	CcSEcCtD
Ergonovine—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	7.28e-05	0.00156	CcSEcCtD
Ergonovine—Hypotension—Irbesartan—type 2 diabetes mellitus	7.24e-05	0.00155	CcSEcCtD
Ergonovine—Ergotamine—CYP1A2—type 2 diabetes mellitus	7.2e-05	0.0472	CrCbGaD
Ergonovine—Shock—Losartan—type 2 diabetes mellitus	7.17e-05	0.00153	CcSEcCtD
Ergonovine—Abdominal pain—Valsartan—type 2 diabetes mellitus	7.13e-05	0.00152	CcSEcCtD
Ergonovine—Nausea—Bromocriptine—type 2 diabetes mellitus	7.1e-05	0.00152	CcSEcCtD
Ergonovine—Hyperhidrosis—Losartan—type 2 diabetes mellitus	7.05e-05	0.00151	CcSEcCtD
Ergonovine—Abdominal pain—Orlistat—type 2 diabetes mellitus	7.04e-05	0.00151	CcSEcCtD
Ergonovine—Vomiting—Glyburide—type 2 diabetes mellitus	6.95e-05	0.00149	CcSEcCtD
Ergonovine—Bromocriptine—CYP1A2—type 2 diabetes mellitus	6.94e-05	0.0455	CrCbGaD
Ergonovine—Dyspnoea—Irbesartan—type 2 diabetes mellitus	6.91e-05	0.00148	CcSEcCtD
Ergonovine—Vertigo—Ramipril—type 2 diabetes mellitus	6.88e-05	0.00147	CcSEcCtD
Ergonovine—Headache—Glyburide—type 2 diabetes mellitus	6.85e-05	0.00146	CcSEcCtD
Ergonovine—Hypotension—Losartan—type 2 diabetes mellitus	6.81e-05	0.00146	CcSEcCtD
Ergonovine—Palpitations—Ramipril—type 2 diabetes mellitus	6.77e-05	0.00145	CcSEcCtD
Ergonovine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	6.71e-05	0.00144	CcSEcCtD
Ergonovine—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	6.71e-05	0.00144	CcSEcCtD
Ergonovine—Chest pain—Ramipril—type 2 diabetes mellitus	6.52e-05	0.0014	CcSEcCtD
Ergonovine—Dyspnoea—Losartan—type 2 diabetes mellitus	6.5e-05	0.00139	CcSEcCtD
Ergonovine—Nausea—Glyburide—type 2 diabetes mellitus	6.49e-05	0.00139	CcSEcCtD
Ergonovine—Abdominal pain—Metformin—type 2 diabetes mellitus	6.49e-05	0.00139	CcSEcCtD
Ergonovine—Dizziness—Gliclazide—type 2 diabetes mellitus	6.49e-05	0.00139	CcSEcCtD
Ergonovine—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	6.34e-05	0.00136	CcSEcCtD
Ergonovine—Vomiting—Gliclazide—type 2 diabetes mellitus	6.24e-05	0.00133	CcSEcCtD
Ergonovine—Diarrhoea—Valsartan—type 2 diabetes mellitus	6.17e-05	0.00132	CcSEcCtD
Ergonovine—Shock—Ramipril—type 2 diabetes mellitus	6.15e-05	0.00132	CcSEcCtD
Ergonovine—Headache—Gliclazide—type 2 diabetes mellitus	6.15e-05	0.00132	CcSEcCtD
Ergonovine—Abdominal pain—Irbesartan—type 2 diabetes mellitus	6.12e-05	0.00131	CcSEcCtD
Ergonovine—Diarrhoea—Orlistat—type 2 diabetes mellitus	6.1e-05	0.0013	CcSEcCtD
Ergonovine—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	6.04e-05	0.00129	CcSEcCtD
Ergonovine—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	5.96e-05	0.00128	CcSEcCtD
Ergonovine—Dizziness—Valsartan—type 2 diabetes mellitus	5.96e-05	0.00128	CcSEcCtD
Ergonovine—Dizziness—Orlistat—type 2 diabetes mellitus	5.89e-05	0.00126	CcSEcCtD
Ergonovine—Hypotension—Ramipril—type 2 diabetes mellitus	5.84e-05	0.00125	CcSEcCtD
Ergonovine—Nausea—Gliclazide—type 2 diabetes mellitus	5.83e-05	0.00125	CcSEcCtD
Ergonovine—Abdominal pain—Losartan—type 2 diabetes mellitus	5.76e-05	0.00123	CcSEcCtD
Ergonovine—Vomiting—Valsartan—type 2 diabetes mellitus	5.73e-05	0.00123	CcSEcCtD
Ergonovine—Pergolide—CYP3A4—type 2 diabetes mellitus	5.71e-05	0.0375	CrCbGaD
Ergonovine—Vomiting—Orlistat—type 2 diabetes mellitus	5.66e-05	0.00121	CcSEcCtD
Ergonovine—Headache—Valsartan—type 2 diabetes mellitus	5.65e-05	0.00121	CcSEcCtD
Ergonovine—Diarrhoea—Metformin—type 2 diabetes mellitus	5.62e-05	0.0012	CcSEcCtD
Ergonovine—Headache—Orlistat—type 2 diabetes mellitus	5.58e-05	0.00119	CcSEcCtD
Ergonovine—Dyspnoea—Ramipril—type 2 diabetes mellitus	5.57e-05	0.00119	CcSEcCtD
Ergonovine—Dizziness—Metformin—type 2 diabetes mellitus	5.43e-05	0.00116	CcSEcCtD
Ergonovine—Nausea—Valsartan—type 2 diabetes mellitus	5.36e-05	0.00115	CcSEcCtD
Ergonovine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	5.3e-05	0.00113	CcSEcCtD
Ergonovine—Nausea—Orlistat—type 2 diabetes mellitus	5.29e-05	0.00113	CcSEcCtD
Ergonovine—Vomiting—Metformin—type 2 diabetes mellitus	5.22e-05	0.00112	CcSEcCtD
Ergonovine—Headache—Metformin—type 2 diabetes mellitus	5.14e-05	0.0011	CcSEcCtD
Ergonovine—Dizziness—Irbesartan—type 2 diabetes mellitus	5.12e-05	0.0011	CcSEcCtD
Ergonovine—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	5.11e-05	0.00109	CcSEcCtD
Ergonovine—Diarrhoea—Losartan—type 2 diabetes mellitus	4.99e-05	0.00107	CcSEcCtD
Ergonovine—Lisuride—CYP3A4—type 2 diabetes mellitus	4.96e-05	0.0325	CrCbGaD
Ergonovine—Abdominal pain—Ramipril—type 2 diabetes mellitus	4.94e-05	0.00106	CcSEcCtD
Ergonovine—Vomiting—Irbesartan—type 2 diabetes mellitus	4.93e-05	0.00105	CcSEcCtD
Ergonovine—Nausea—Metformin—type 2 diabetes mellitus	4.88e-05	0.00104	CcSEcCtD
Ergonovine—Headache—Irbesartan—type 2 diabetes mellitus	4.85e-05	0.00104	CcSEcCtD
Ergonovine—Dizziness—Losartan—type 2 diabetes mellitus	4.82e-05	0.00103	CcSEcCtD
Ergonovine—Ergotamine—CYP3A4—type 2 diabetes mellitus	4.77e-05	0.0313	CrCbGaD
Ergonovine—Vomiting—Losartan—type 2 diabetes mellitus	4.64e-05	0.000992	CcSEcCtD
Ergonovine—Nausea—Irbesartan—type 2 diabetes mellitus	4.6e-05	0.000985	CcSEcCtD
Ergonovine—Bromocriptine—CYP3A4—type 2 diabetes mellitus	4.59e-05	0.0301	CrCbGaD
Ergonovine—Headache—Losartan—type 2 diabetes mellitus	4.57e-05	0.000977	CcSEcCtD
Ergonovine—Nausea—Losartan—type 2 diabetes mellitus	4.33e-05	0.000927	CcSEcCtD
Ergonovine—Diarrhoea—Ramipril—type 2 diabetes mellitus	4.28e-05	0.000915	CcSEcCtD
Ergonovine—Dizziness—Ramipril—type 2 diabetes mellitus	4.13e-05	0.000885	CcSEcCtD
Ergonovine—Vomiting—Ramipril—type 2 diabetes mellitus	3.98e-05	0.00085	CcSEcCtD
Ergonovine—Headache—Ramipril—type 2 diabetes mellitus	3.92e-05	0.000838	CcSEcCtD
Ergonovine—Nausea—Ramipril—type 2 diabetes mellitus	3.71e-05	0.000794	CcSEcCtD
Ergonovine—HTR2C—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	3.64e-06	0.000172	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	3.64e-06	0.000172	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—PSMD6—type 2 diabetes mellitus	3.63e-06	0.000171	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—HTR2C—type 2 diabetes mellitus	3.63e-06	0.000171	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	3.63e-06	0.000171	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.63e-06	0.000171	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.63e-06	0.000171	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	3.63e-06	0.000171	CbGpPWpGaD
Ergonovine—ABCB1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	3.58e-06	0.000169	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—AGT—type 2 diabetes mellitus	3.58e-06	0.000169	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—EDNRA—type 2 diabetes mellitus	3.53e-06	0.000166	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—CALM1—type 2 diabetes mellitus	3.52e-06	0.000166	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CYBA—type 2 diabetes mellitus	3.52e-06	0.000166	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—GLP1R—type 2 diabetes mellitus	3.49e-06	0.000164	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—CCL2—type 2 diabetes mellitus	3.47e-06	0.000163	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	3.46e-06	0.000163	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—GHRL—type 2 diabetes mellitus	3.44e-06	0.000162	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—PLAT—type 2 diabetes mellitus	3.44e-06	0.000162	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	3.42e-06	0.000161	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	3.42e-06	0.000161	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—RELA—type 2 diabetes mellitus	3.41e-06	0.000161	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—AKT2—type 2 diabetes mellitus	3.41e-06	0.00016	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	3.4e-06	0.00016	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CALCA—type 2 diabetes mellitus	3.4e-06	0.00016	CbGpPWpGaD
Ergonovine—ABCB1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	3.36e-06	0.000158	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	3.34e-06	0.000157	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	3.31e-06	0.000156	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—SLC2A2—type 2 diabetes mellitus	3.26e-06	0.000154	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	3.22e-06	0.000152	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	3.2e-06	0.000151	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—MTR—type 2 diabetes mellitus	3.19e-06	0.00015	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—CPT1A—type 2 diabetes mellitus	3.19e-06	0.00015	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—GNB3—type 2 diabetes mellitus	3.19e-06	0.00015	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	3.19e-06	0.00015	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	3.18e-06	0.00015	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	3.18e-06	0.00015	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	3.18e-06	0.00015	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—AVP—type 2 diabetes mellitus	3.15e-06	0.000148	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—GCG—type 2 diabetes mellitus	3.15e-06	0.000148	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—PTPN1—type 2 diabetes mellitus	3.15e-06	0.000148	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—MMP3—type 2 diabetes mellitus	3.15e-06	0.000148	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—IGF2—type 2 diabetes mellitus	3.14e-06	0.000148	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—NAMPT—type 2 diabetes mellitus	3.13e-06	0.000148	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	3.12e-06	0.000147	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—HBA1—type 2 diabetes mellitus	3.11e-06	0.000147	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—GCK—type 2 diabetes mellitus	3.11e-06	0.000147	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—LIPC—type 2 diabetes mellitus	3.11e-06	0.000147	CbGpPWpGaD
Ergonovine—HTR1E—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.11e-06	0.000146	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	3.1e-06	0.000146	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—CYP11A1—type 2 diabetes mellitus	3.09e-06	0.000146	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	3.09e-06	0.000146	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	3.09e-06	0.000145	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.08e-06	0.000145	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.06e-06	0.000144	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	3.05e-06	0.000144	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	3.05e-06	0.000144	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—APOB—type 2 diabetes mellitus	3.04e-06	0.000143	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—SLC9A1—type 2 diabetes mellitus	3.04e-06	0.000143	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—IGF1R—type 2 diabetes mellitus	3.03e-06	0.000143	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—CETP—type 2 diabetes mellitus	3e-06	0.000141	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—EDN1—type 2 diabetes mellitus	3e-06	0.000141	CbGpPWpGaD
Ergonovine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	2.95e-06	0.000139	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—CCL2—type 2 diabetes mellitus	2.95e-06	0.000139	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	2.94e-06	0.000138	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	2.94e-06	0.000138	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.91e-06	0.000137	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—LPL—type 2 diabetes mellitus	2.91e-06	0.000137	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—AKT2—type 2 diabetes mellitus	2.9e-06	0.000136	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	2.89e-06	0.000136	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	2.89e-06	0.000136	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.88e-06	0.000136	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—ADCY5—type 2 diabetes mellitus	2.85e-06	0.000134	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	2.84e-06	0.000134	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	2.84e-06	0.000134	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	2.84e-06	0.000134	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.82e-06	0.000133	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—SNAP25—type 2 diabetes mellitus	2.79e-06	0.000131	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—SREBF1—type 2 diabetes mellitus	2.79e-06	0.000131	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—PSMD6—type 2 diabetes mellitus	2.79e-06	0.000131	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	2.74e-06	0.000129	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—CTGF—type 2 diabetes mellitus	2.74e-06	0.000129	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	2.73e-06	0.000128	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—HMGCR—type 2 diabetes mellitus	2.71e-06	0.000128	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—GNB3—type 2 diabetes mellitus	2.71e-06	0.000128	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—SRC—type 2 diabetes mellitus	2.68e-06	0.000126	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CCR5—type 2 diabetes mellitus	2.68e-06	0.000126	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—AVP—type 2 diabetes mellitus	2.68e-06	0.000126	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—MMP3—type 2 diabetes mellitus	2.68e-06	0.000126	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	2.67e-06	0.000126	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—IGF2—type 2 diabetes mellitus	2.67e-06	0.000126	CbGpPWpGaD
Ergonovine—ABCB1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	2.66e-06	0.000125	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—ADRA2A—type 2 diabetes mellitus	2.66e-06	0.000125	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	2.65e-06	0.000125	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	2.63e-06	0.000124	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—C3—type 2 diabetes mellitus	2.62e-06	0.000123	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.61e-06	0.000123	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—APOB—type 2 diabetes mellitus	2.59e-06	0.000122	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—IGF1R—type 2 diabetes mellitus	2.58e-06	0.000121	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—CYP2E1—type 2 diabetes mellitus	2.55e-06	0.00012	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—EDN1—type 2 diabetes mellitus	2.55e-06	0.00012	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—SLC2A1—type 2 diabetes mellitus	2.52e-06	0.000119	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—CYP1A2—type 2 diabetes mellitus	2.52e-06	0.000119	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	2.5e-06	0.000118	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—HIF1A—type 2 diabetes mellitus	2.5e-06	0.000118	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—IRS2—type 2 diabetes mellitus	2.49e-06	0.000117	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—AGT—type 2 diabetes mellitus	2.49e-06	0.000117	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—LPL—type 2 diabetes mellitus	2.47e-06	0.000116	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	2.46e-06	0.000116	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CALM1—type 2 diabetes mellitus	2.44e-06	0.000115	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—APOE—type 2 diabetes mellitus	2.44e-06	0.000115	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—LEP—type 2 diabetes mellitus	2.44e-06	0.000115	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	2.42e-06	0.000114	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	2.42e-06	0.000114	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—ADCY5—type 2 diabetes mellitus	2.42e-06	0.000114	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	2.41e-06	0.000114	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	2.41e-06	0.000114	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	2.41e-06	0.000114	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	2.41e-06	0.000114	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—APOA1—type 2 diabetes mellitus	2.41e-06	0.000113	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.4e-06	0.000113	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.35e-06	0.000111	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	2.32e-06	0.000109	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	2.31e-06	0.000109	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—PRKCB—type 2 diabetes mellitus	2.3e-06	0.000108	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CCR5—type 2 diabetes mellitus	2.28e-06	0.000107	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—C3—type 2 diabetes mellitus	2.22e-06	0.000105	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.17e-06	0.000102	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	2.15e-06	0.000101	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—HIF1A—type 2 diabetes mellitus	2.12e-06	0.0001	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—IRS2—type 2 diabetes mellitus	2.12e-06	9.97e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—AGT—type 2 diabetes mellitus	2.11e-06	9.96e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.09e-06	9.83e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	2.09e-06	9.83e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—INS—type 2 diabetes mellitus	2.08e-06	9.8e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CALM1—type 2 diabetes mellitus	2.08e-06	9.79e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	2.08e-06	9.78e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—LEP—type 2 diabetes mellitus	2.07e-06	9.76e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—APOE—type 2 diabetes mellitus	2.07e-06	9.76e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	2.05e-06	9.65e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.05e-06	9.65e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—APOA1—type 2 diabetes mellitus	2.05e-06	9.65e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.01e-06	9.48e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.01e-06	9.48e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	2.01e-06	9.46e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2e-06	9.44e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	1.99e-06	9.37e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	1.97e-06	9.27e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	1.97e-06	9.27e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.95e-06	9.2e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	1.93e-06	9.11e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	1.93e-06	9.09e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	1.92e-06	9.03e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	1.92e-06	9.03e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	1.92e-06	9.03e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.91e-06	9.01e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	1.91e-06	8.98e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	1.9e-06	8.95e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	1.87e-06	8.81e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	1.86e-06	8.76e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	1.85e-06	8.73e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	1.85e-06	8.71e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.85e-06	8.71e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.82e-06	8.6e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.82e-06	8.6e-05	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—IL6—type 2 diabetes mellitus	1.81e-06	8.52e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	1.8e-06	8.5e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	1.78e-06	8.39e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—INS—type 2 diabetes mellitus	1.77e-06	8.34e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.74e-06	8.2e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	1.72e-06	8.1e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	1.72e-06	8.1e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	1.72e-06	8.1e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—RELA—type 2 diabetes mellitus	1.72e-06	8.09e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.71e-06	8.06e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.71e-06	8.06e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	1.71e-06	8.05e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.7e-06	8.02e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	1.69e-06	7.95e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	1.68e-06	7.9e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	1.67e-06	7.88e-05	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.67e-06	7.86e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	1.64e-06	7.71e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.63e-06	7.66e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	1.62e-06	7.65e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	1.6e-06	7.52e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	1.59e-06	7.5e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	1.57e-06	7.41e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	1.57e-06	7.41e-05	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.56e-06	7.37e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	1.55e-06	7.33e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	1.55e-06	7.33e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.55e-06	7.31e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.55e-06	7.31e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.55e-06	7.3e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.54e-06	7.25e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	1.49e-06	7.02e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	1.49e-06	7.02e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.46e-06	6.9e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—RELA—type 2 diabetes mellitus	1.46e-06	6.88e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.45e-06	6.82e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.42e-06	6.69e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	1.39e-06	6.53e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—INS—type 2 diabetes mellitus	1.36e-06	6.41e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—SRC—type 2 diabetes mellitus	1.35e-06	6.36e-05	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.33e-06	6.26e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.32e-06	6.21e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.31e-06	6.19e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.31e-06	6.17e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.28e-06	6.05e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	1.28e-06	6.05e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	1.28e-06	6.03e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	1.26e-06	5.95e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	1.25e-06	5.87e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.24e-06	5.87e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.23e-06	5.8e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	1.23e-06	5.77e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.21e-06	5.69e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.21e-06	5.69e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	1.19e-06	5.62e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.19e-06	5.62e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	1.19e-06	5.61e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.18e-06	5.57e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	1.17e-06	5.51e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—SRC—type 2 diabetes mellitus	1.15e-06	5.41e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	1.15e-06	5.4e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	1.14e-06	5.38e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.12e-06	5.27e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	1.11e-06	5.24e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	1.1e-06	5.17e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	1.09e-06	5.14e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	1.05e-06	4.96e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	1.03e-06	4.87e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.03e-06	4.83e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.01e-06	4.74e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	1e-06	4.71e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	9.84e-07	4.64e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	9.81e-07	4.62e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	9.69e-07	4.57e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—IL6—type 2 diabetes mellitus	9.09e-07	4.28e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	8.54e-07	4.02e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—AKT1—type 2 diabetes mellitus	8.39e-07	3.95e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	8.38e-07	3.95e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—IL6—type 2 diabetes mellitus	7.73e-07	3.64e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	7.68e-07	3.62e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	7.35e-07	3.46e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	7.35e-07	3.46e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.13e-07	3.36e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	6.72e-07	3.17e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	5.48e-07	2.58e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	3.38e-07	1.59e-05	CbGpPWpGaD
